Species: Treponema medium (HMT-0667) Primary Body Site: Oral
Download Options
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.26 | 0.04 | 0.62 | 0 | 0.01 | 0 | 0.03 | 0.01 | 0.06 | 0.02 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0 | 0 | 0.02 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 |
| 90thp | 0.47 | 0.11 | 1.27 | 0.01 | 0.02 | 0 | 0.05 | 0.02 | 0.18 | 0.04 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 |
| Stdev | 0.63 | 0.11 | 0.91 | 0.01 | 0.02 | 0 | 0.02 | 0.01 | 0.07 | 0.04 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 |
| Prev(%) | 41.67 | 17.97 | 58.33 | 0 | 0.31 | 0 | 0 | 0 | 13.64 | 16.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
Notes:
reads equally close to T. medium and T. vincentii were assigned half to each taxon
reads equally close to T. medium and T. vincentii were assigned half to each taxon
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.02 | 0.01 | 0 | 0 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.07 | 0.01 | 0 | 0 | 0.02 | 0.04 | 0.06 | 0.06 | 0.04 | 0 |
| Stdev | 0.05 | 0.04 | 0 | 0.01 | 0.02 | 0.03 | 0.04 | 0.04 | 0.05 | 0 |
| Prev(%) | 20.78 | 10.39 | 2.60 | 10.39 | 22.08 | 28.57 | 27.27 | 25.97 | 28.57 | 1.30 |
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
Notes:
Reads equally close to T. medium and T. sp. HMT 226, 230, 235, and 237 were assigned one-fifth to each taxon.
Reads equally close to T. medium and T. sp. HMT 226, 230, 235, and 237 were assigned one-fifth to each taxon.
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.12 | 0.04 | 0 | 0.01 | 0 | 0.02 | 0.01 | 0.03 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.37 | 0.06 | 0 | 0.02 | 0.01 | 0.04 | 0.01 | 0.07 | 0 | 0 |
| Stdev | 0.31 | 0.12 | 0 | 0.02 | 0.01 | 0.03 | 0.02 | 0.08 | 0.01 | 0 |
| Prev(%) | 50.68 | 35.13 | 3.38 | 22.97 | 14.87 | 45.95 | 27.03 | 39.19 | 6.08 | 0 |
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
Notes:
Reads equidistant to HMT-231 and HMT-667 were assigned to each taxon in proportion to the abundance of HMT-231 and HMT-667 individually at these sites (PTO,THR,TDO).
Reads equidistant to HMT-231 and HMT-667 were assigned to each taxon in proportion to the abundance of HMT-231 and HMT-667 individually at these sites (PTO,THR,TDO).
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0 | 0 | 0 | 0.02 | 0 | 0.03 | 0.01 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0 | 0 | 0 | 0.07 | 0 | 0.07 | 0.04 | 0.13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0 | 0 | 0 | 0 | 0.04 | 0 | 0.08 | 0.04 | 0.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 0 | 0 | 0 | 0 | 26.85 | 0 | 30.06 | 34.00 | 34.19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
No Notes
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.04 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 |
| Stdev | 0.03 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0.06 | 0 | 0 |
| Prev(%) | 33.78 | 32.35 | 4.65 | 11.43 | 7.14 | 20.00 | 24.24 | 25.81 | 12.50 | 0 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0 | 0.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0 | 0 | 0.28 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 0 | 0.76 | 29.17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
